Differences in clinical sensitivity of ELISA tests for autoantibodies with human and bovine extractable nuclear antigens

Abstract

Bovine antigens are routinely used in indirect ELISA tests to detect autoantibodies against extractable nuclear antigens (ENA). Here we investigate the difference in clinical sensitivity between ELISA tests prepared with native human and bovine antigens. SSA and SSB were obtained from spleen and nRNP/Sm complex from thymus. Each antigen was extracted with the same immunoaffinity column. ELISA tests with human and bovine antigens were set up under the same conditions of clinical specificity established on 50 blood bank donors. Of 109 random SLE and Sjogren's syndrome sera 49% and 35% were positive, respectively, for human and bovine SSA, 26% and 16% for SSB. Of 98 random SLE sera 52% and 41% were positive for human and bovine nRNP/Sm, respectively. A few specimens reacted only with bovine antigens, probably false positive reactions. The relative clinical sensitivity for all specimens identified as positive by human and/or bovine antigens was significantly higher with human than with bovine SSA, (93% vs 67%; P < 0.001, χ²), SSB (93% vs 50%; P < 0.001), and for nRNP/Sm (96% vs 75%; P < 0.01). However, for values that exceeded 2.5–4 times the upper normal limit, the levels were similar for human and bovine antigens. We concluded that native human antigens offer clinical sensitivity superior to native bovine antigens for the measurement of anti-ENA antibodies by ELISA.

Keywords

extractable nuclear antigens systemic lupus erythematosus human antigens ELISA

Get full access to this article

View all access options for this article.

References

Elkon K . Systemic lupus erythematosus – Autoantibodies in SLE. In: Klippel JH , Dieppe PA (ed). Rheumatology. Mosby: London , 1994, pp 4.1–4.10.

Froelich CJ , Wallman J , Skosey JL , Teodorescu M . Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA, and SSB) . J Rheumatol 1990; 17: 192–200 .

Collins RJ , Neil JC , Druery LN , Wilson RJ . Detection of antibodies to extractable nuclear antigens using calf thymus and rabbit thymus . J Immunol Meth 1989; 116: 53–57 .

Douvas AS , Achten M , Tan EM . Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma . J Biol Chem 1979; 254: 1051–1054 .

Kurata N , Tan E . Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis . Arthritis Rheum 1976; 19: 574–579 .

Northway J , Tan E . Differentation of anti-nuclear antibodies giving speckled staining patterns in immunofluoresence . Clin Immunol Immunopathol 1972; 1: 140–148 .

James J , Dickey W , Fujisaku A et al. Antigenicity of a recombinant Ro (SSA) fusion protein . Arthritis Rheum 1990; 33: 102–106 .

van Venrooij WJ , Charles P , Maini RN . The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases . J Immunol Meth 1991; 140: 181–189 .

Teodorescu M , Froelich CJ . Laboratory evaluation of systemic lupus erythematosus. In: Lahita RG (ed). Systemic Lupus Erythematosus 3rd edn. Academic Press: San Diego , 1999, pp 477–505.

10.

Chan EKL , Sullivan KF , Tan EM . Ribonucleoprotein SS-B/La belongs to a protein family with consensus sequence for RNA-binding . Nucleic Acids Res 1989; 17: 2233–2244 .

11.

Reichlin M , Rader M , Harley JB . Autoimmune response to the Ro/SSA particle is directed to the human antigen . Clin Exp Immunol 1989; 76: 373–377 .

12.

Tan E , Cohen A , Fries J et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271–1279 .

13.

Gladman DD , Urowitz MB . Systemic lupus erythematosus-Clinical features. In: Klippel JH , Dieppe PA (ed). Rheumatology. Mosby: London , 1998, pp 2.1–2.20.

14.

Reichlin M , Harley JB . Antibodies to Ro (SSA) and the heterogeneity of SLE . J Rheumatol 1987; 14: 112–117 .

15.

Campbell RC . Statistics for Biologists 2nd edn. Cambridge University Press: Cambridge , 1979.

16.

Young DS . Determination and validation of reference ranges . Arch Path Lab Med 1992; 116: 704–709 .

17.

Fanopoulos D , Teodorescu MR , Varga J , Teodorescu M . High frequency of abnormal levels of IgA anti-b2 Glycoprotein 1 antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome . J Rheumatol 1998; 25: 675–680 .

18.

Teodorescu M , Froelich CJ . ELISA and other immunologic techniques in rheumatology. In: Teodorescu M , Froelich CJ (ed). Advanced Immunoassays in Rheumatology. CRC Press: Boca Raton , 1994, pp 3–26.

19.

Reichlin M , Scofield RH . SSA (Ro) autoantibodies. In: Peter JB , Shoenfeld Y (ed). Autoantibodies. Elsevier: Amsterdam , 1996, pp 783–788.

20.

Yamagata H , Harley JB , Reichlin M . Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody . J Clin Invest 1984; 74: 625–633 .

21.

Weng YM , McNeilage J , Topfer F et al. Identification of a humanspecific epitope in a conserved region of the La/SS-B autoantigen . J Clin Invest 1993; 92: 1104–1108 .

22.

Burek CL , Rose NR . Thyoglobulin autoantibodies. In: Peter JB , Shoenfeld Y (ed). Autoantibodies. Elsevier: Amsterdam , 1996, pp 810–815.

23.

Roubey RAS . Immunology of the antiphospholipid antibody syndrome . Arthritis Rheum 1996; 39: 1444–1454 .

24.

McCauliffe DP , Yin H , Wang LX , Lucas L . Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro(SSA) proteins . J Rheumatol 1994; 21: 1073–1080 .

25.

Wagatsuma M , Asami N , Miyachi J et al. Antibody recognition of the recombinant human nuclear antigens RNP 70kD, SS-A, SS-B, Sm-B and Sm-D by autoimmune sera . Mol Immunol 1993; 30: 1491–1498 .